GlassScriptPhysician profile
Robert B O Malley
NPI 1528080389
$3,397.60
in general payments reported to CMS, 2019-2025
20 companies · $69.18 in 2025
The $69.18 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $152 · 2021: $878 · 2022: $1,143 · 2023: $305 · 2024: $340 · 2025: $69.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,758.46 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $409.23 | 2023-2024 | Nuzyra |
| Horizon Therapeutics Plc | $332.53 | 2019-2020 | |
| Smith+Nephew, INC. | $155.55 | 2019-2020 | |
| Trice Medical, INC. | $108.81 | 2024 | |
| Endo Pharmaceuticals INC. | $100.30 | 2020-2022 | |
| Organogenesis INC. | $96.25 | 2022 | |
| Avanos Medical | $54.00 | 2019 | |
| Endo USA, INC. | $52.82 | 2024-2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $52.03 | 2024-2025 | |
| Stryker Corporation | $46.55 | 2022 | |
| Zyla Life Sciences, INC. | $46.16 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $41.07 | 2023 | Seglentis |
| Acelrx Pharmaceuticals, INC. | $29.16 | 2020-2021 | |
| Orthofix Medical, INC. | $25.85 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $24.69 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.36 | 2023 | Exparel, Iovera, Zilretta |
| Si-Bone, INC. | $17.59 | 2023 | |
| Checkpoint Surgical, INC | $14.94 | 2024 | Checkpoint Stimulators |
| Ossio INC | $13.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert O Malley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.